Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials

Vaccine. 2007 Aug 10;25(32):6140-5. doi: 10.1016/j.vaccine.2007.01.110. Epub 2007 Feb 16.

Abstract

In order to evaluate whether cattle vaccinated with an inactivated vaccine against bovine viral diarrhoea virus (BVDV) can be differentiated serologically from BVDV infected animals, two different aspects were investigated. Firstly the antibody response against non-structural proteins (NS) was measured after multiple vaccinations of cattle with a single or double dose of a commercially available inactivated BVDV vaccine. In a second study, the animals were first vaccinated with the product, and then infected with BVDV. The antibody response was determined in four different commercial ELISA systems. It can be concluded, that the inactivated BVD vaccine exhibits properties of a marker vaccine when an appropriate antibody NS3 ELISA is applied: after vaccination NS3-specific antibody levels are low or undetectable, but the vaccination does in the present study not show any interference with the development of antibodies against NS3 after subsequent field virus infection.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • Bovine Virus Diarrhea-Mucosal Disease / immunology*
  • Bovine Virus Diarrhea-Mucosal Disease / prevention & control*
  • Cattle
  • Diarrhea Viruses, Bovine Viral / immunology*
  • Drug Administration Schedule / veterinary
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Peptide Hydrolases / immunology*
  • RNA Helicases / immunology*
  • Vaccination
  • Viral Nonstructural Proteins / immunology*
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Viral
  • Viral Nonstructural Proteins
  • Viral Vaccines
  • p80 protein, bovine viral diarrhea virus
  • Peptide Hydrolases
  • RNA Helicases